161.91

1.80% -2.97

After Hours: 163.00 1.09 +0.67%

Iqvia Holdings Inc (IQV)

Overview News Price History Option Chain Financials Discussions Forecast

Iqvia Holdings Inc stock is traded at $161.91, with a volume of 3.19M. It is down -1.80% in the last 24 hours and down -31.19% over the past month. Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Previous Close:

$164.88

Open:

$166.385

24h Volume:

3.19M

Relative Volume:

1.76

Market Cap:

$27.48B

Revenue:

$16.30B

Net Income/Loss:

$1.36B

P/E Ratio:

20.61

EPS:

7.8573

Net Cash Flow:

$2.05B

1W Performance:

-5.35%

1M Performance:

-31.19%

6M Performance:

-13.87%

1Y Performance:

-15.22%

1-Day Range:

$160.00

$166.38

1-Week Range:

$159.67

$171.06

52-Week Range:

$134.65

$247.04

Iqvia Holdings Inc Stock (IQV) Company Profile

Name

Iqvia Holdings Inc

Sector

Healthcare (1108)

Industry

Diagnostics & Research (53)

Phone

919-998-2000

Address

2400 ELLIS ROAD, DURHAM, NC

Employee

93,000

Twitter

@IQVIA_global

Next Earnings Date

2025-07-22

Latest SEC Filings

IQV's Discussions on Twitter

Compare IQV vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IQV Iqvia Holdings Inc	161.91	27.98B	16.30B	1.36B	2.05B	7.8573
TMO Thermo Fisher Scientific Inc	513.68	193.72B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	209.52	147.88B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	657.38	51.84B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	124.72	35.19B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	319.44	32.01B	3.17B	642.63M	516.49M	10.77

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Overweight
Nov-13-25	Initiated	BMO Capital Markets	Outperform
Nov-03-25	Downgrade	TD Cowen	Buy → Hold
Oct-29-25	Upgrade	Robert W. Baird	Neutral → Outperform
Oct-09-25	Upgrade	HSBC Securities	Hold → Buy
Sep-09-25	Upgrade	Jefferies	Hold → Buy
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform
Jul-24-24	Downgrade	Jefferies	Buy → Hold
Jun-06-24	Initiated	Goldman	Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-06-23	Initiated	HSBC Securities	Buy
Mar-17-23	Initiated	Truist	Buy
Dec-06-22	Initiated	Cowen	Outperform
Nov-17-22	Downgrade	Citigroup	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-15-22	Initiated	SVB Leerink	Outperform
May-24-22	Initiated	Guggenheim	Buy
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-05-21	Resumed	Credit Suisse	Outperform
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-03-21	Initiated	Barclays	Overweight
Jul-07-20	Initiated	Stephens	Equal-Weight
Mar-02-20	Initiated	Deutsche Bank	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Dec-13-19	Upgrade	CFRA	Sell → Hold
Nov-14-19	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-21-19	Upgrade	Mizuho	Neutral → Buy
May-28-19	Initiated	SVB Leerink	Outperform
Jan-18-19	Upgrade	Jefferies	Hold → Buy
Oct-09-18	Initiated	UBS	Buy
Oct-02-18	Reiterated	Robert W. Baird	Outperform
Jul-25-18	Upgrade	BofA/Merrill	Neutral → Buy
Jul-25-18	Reiterated	Stifel	Buy
Jul-03-18	Upgrade	Raymond James	Outperform → Strong Buy
Apr-13-18	Upgrade	Goldman	Neutral → Buy
Mar-07-18	Upgrade	SunTrust	Hold → Buy
Jan-19-18	Initiated	Evercore ISI	Outperform

View All

Iqvia Holdings Inc Stock (IQV) Latest News

Feb 25, 2026

IQVIA Holdings Inc. (NYSE : IQV) entered into a definitive agreement to acquire European Discovery Services Assets from Charles River Laboratories International, Inc. (NYSE - marketscreener.com

Feb 25, 2026

IQVIA to acquire drug discovery assets from Charles River Labs By Investing.com - Investing.com Nigeria

Feb 25, 2026

Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans - Benzinga

Feb 25, 2026

Did AI‑Driven Obesity Research Wins and Strong 2025 Results Just Shift IQVIA's (IQV) Investment Narrative? - simplywall.st

Feb 25, 2026

IQVIA to acquire drug discovery assets from Charles River Labs - Investing.com

Feb 25, 2026

Charles River raises annual profit view as it sells underperforming assets - marketscreener.com

Feb 25, 2026

Iqvia signs agreement to acquire drug discovery assets from Charles River Laboratories, expanding end-to-end drug discovery capabilities - marketscreener.com

Feb 25, 2026

Charles River Laboratories Provides Update on Planned Divestitures - Business Wire

Feb 25, 2026

Feb 24, 2026